William Blair has been made aware of fraudulent activity involving individuals impersonating our employees and brand, including through fake websites and messaging apps like WhatsApp and Telegram. If you have any questions or concerns about someone from William Blair contacting you, please reach out to us via our Contact Us form. Please note — William Blair will never initiate contact with you via messaging apps.
William Blair macro analyst Richard de Chazal unpacks the latest on global tariffs, inflation pressures, recession risks, and why smidcap stocks might be poised for a comeback in a shifting economic landscape.
Read more
Recent tariff-related disruptions have significantly expanded the scope of M&A due diligence, with buyers now asking target companies an array of questions to assess new trade policy risk.
Read more
Discover the ways William Blair client Bob Crawford Jr. is helping business owners unlock capital, coaching, and connections to strengthen Chicago communities.
Read more
At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.
Learn more about our mission, vision, and values
We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.
More about our community partners
William Blair acted as exclusive financial advisor to Brightflag, a portfolio company of One Peak Partners, Sands Capital, Frontline Ventures, Tribal Ventures, and Enterprise Ireland, in connection with its pending sale to Wolters Kluwer (EURONEXT: WKL) for €425 million.
William Blair initiated research coverage of Ultragenyx Pharmaceutical Inc. (RARE $35.66), a commercial-stage, modality-agnostic biotechnology company specializing in developing therapies for the treatment of rare and ultrarare genetic diseases.
Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.
Search our job openings
Stay up-to-date with the latest William Blair news and insights
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
